Navigation Links
OLIGOMERIX Awarded NIH Grant to Develop Novel Biomarkers for Alzheimer's Disease
Date:2/25/2009

l AD targets.

For more information visit www.oligomerix.com.

Certain matters described in this news release may be forward-looking statements subject to risks and uncertainties that could cause actual results to differ materially from those indicated. Risks and uncertainties include, but are not limited to, the risk of dependence on market growth, competition and dependence on government agencies and other third parties for funding, contract research, and services.

    CONTACTS:
    OLIGOMERIX, Inc.
    James Moe, President and CEO
    212-568-0365 Ext. 18
    jmoe@oligomerix.com

    Richard Lewis Communications, Inc.
    212-827-0020
    Cecelia Heer, Investors
    cheer@rlcinc.com
    Gregory Tiberend, Media
    gtiberend@rlcinc.com


'/>"/>
SOURCE OLIGOMERIX, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Peter Zoller and Ignacio Cirac, awarded by the BBVA Foundation
2. Origin BioMed Awarded Red Herring Top 100 Global Company
3. Modigene Awarded Second-Year Grant by Israeli Government to Support Development of Its Longer-Acting Human Growth Hormone
4. Eurotech Catalyst Module Awarded to Allen Organ Company From Arrow Electronics
5. Omeros Awarded Grant from The Michael J. Fox Foundation to Evaluate Novel Parkinsons Disease Target
6. Probiotic Delivery Technology Awarded Third International Patent
7. Epeius Biotech Awarded Patents in Europe for Targeted Genetic Anti-Cancer Medicine: Company Expands Impressive Intellectual Property Estate
8. China Medicine Corporation Awarded GSP Certification
9. Shasta Regional Medical Center Awarded Full Accreditation from the Joint Commission
10. Transgenomic Awarded SBIR Grant to Support Development of SURVEYOR(R) Endonuclease Adaptor-ligated Libraries (SEAL) for Determining Whole Genome Sequence Variation
11. Yale professor T.P. Ma awarded the Connecticut Medal of Technology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)...  RXi Pharmaceuticals Corporation (NASDAQ: RXII ), ... innovative therapies primarily in the areas of dermatology ... of the Company,s Series A and Series A-1 ... http://photos.prnewswire.com/prnh/20130917/NE80755LOGO At March 31, ... Series A Preferred Stock and Series A-1 Preferred ...
(Date:5/26/2015)... 2015 Regenestem Network has ... clinic in Buenos Aires, Argentina. The clinic will be ... specialist. Pastrana has assembled a multidisciplinary team of medical ... her state-of-the-art Puerto Madero office. , The new ... phase IV clinical studies in cellular therapies, and establish ...
(Date:5/26/2015)... HILDEN, Germany , May 26, ... QGEN ; Frankfurt Prime Standard: QIA) today ... Insight ® (QCI™) bioinformatics content and software ... report on genomic variants identified in next-generation sequencing ... bioinformatics platform are in oncology, for somatic and ...
(Date:5/26/2015)... CHENGDU, China , May 26, 2015 ... pharmaceutical company that specializes in the patented biopharmaceutical, modernized ... ingredients (API), announced that the Company,s Annual Meeting of ... was scheduled to be held at the Company,s office ... via conference call, at 9:00 AM (local time in ...
Breaking Biology Technology:RXi Pharmaceuticals Provides an Update on Series A and Series A-1 Preferred Stock 2RXi Pharmaceuticals Provides an Update on Series A and Series A-1 Preferred Stock 3Regenestem Network and Silvina Pastrana, M.D. Announce the Opening of a New Stem Cell Clinic in Buenos Aires 2Regenestem Network and Silvina Pastrana, M.D. Announce the Opening of a New Stem Cell Clinic in Buenos Aires 3QIAGEN Launches Clinical Bioinformatics Platform for Next-Generation Sequencing 2QIAGEN Launches Clinical Bioinformatics Platform for Next-Generation Sequencing 3QIAGEN Launches Clinical Bioinformatics Platform for Next-Generation Sequencing 4QIAGEN Launches Clinical Bioinformatics Platform for Next-Generation Sequencing 5TPI Adjourned Its 2014 Annual Shareholder Meeting and Received Notice of Non-Compliance with NYSE MKT Continued Listing Requirements 2TPI Adjourned Its 2014 Annual Shareholder Meeting and Received Notice of Non-Compliance with NYSE MKT Continued Listing Requirements 3
... Aug. 14 /Xinhua-PRNewswire-FirstCall/ -- China Sky One,Medical, ... Company,) (Amex: CSY ), a,leading fully ... in the People,s Republic of China ("PRC"), ... spray for the treatment,and prevention of rheumatic ...
... Technology ... ... (Nasdaq: PRXL ), a leading global biopharmaceutical services,organization, today ... leading clinical technology organization. By combining,ClinPhone with Perceptive Informatics, PAREXEL,s ...
... to Host Conference Call at 4:30 p.m. ET Today -, ... ) today reported financial results for its fourth quarter,and fiscal ... fourth quarter of,fiscal 2008 was $4.6 million, or $0.18 per ... per share, for the fourth quarter of fiscal 2007., ...
Cached Biology Technology:China Sky One Medical, Inc. Develops Nasal Spray for Rheumatic Disease 2China Sky One Medical, Inc. Develops Nasal Spray for Rheumatic Disease 3PAREXEL Closes the Acquisition of ClinPhone 2PAREXEL Closes the Acquisition of ClinPhone 3PAREXEL Closes the Acquisition of ClinPhone 4PAREXEL Closes the Acquisition of ClinPhone 5Pharmacyclics Reports Fourth Quarter and Fiscal 2008 Financial Results 2Pharmacyclics Reports Fourth Quarter and Fiscal 2008 Financial Results 3Pharmacyclics Reports Fourth Quarter and Fiscal 2008 Financial Results 4Pharmacyclics Reports Fourth Quarter and Fiscal 2008 Financial Results 5Pharmacyclics Reports Fourth Quarter and Fiscal 2008 Financial Results 6
(Date:4/27/2015)... 27, 2015 NXT-ID, Inc. (NASDAQ: NXTD ... focused on the growing mobile commerce market, announces that ... customers the first week of May, 2015 and will ... May. Gino Pereira , Chief ... the company as Wocket® enters the consumer market. We ...
(Date:4/20/2015)... , April 20, 2015 Huntington Memorial ... Valley to implant a new miniaturized, wireless monitoring sensor ... is the first and only FDA-approved heart failure monitoring ... admissions when used by physicians to manage heart failure. ... that is implanted in the pulmonary artery (PA) during ...
(Date:4/14/2015)... 14, 2015  HYPR Corp. today announced it ... ) Alliance tm , an industry consortium transforming ... to share technology and collaborate to deliver open ... more secure and private, and easier to use. ... that protects sensitive user information and eliminates the ...
Breaking Biology News(10 mins):Wocket, the Smartest Wallet You Will Ever Own, Announces Shipment to Pre-order Customers 2Wocket, the Smartest Wallet You Will Ever Own, Announces Shipment to Pre-order Customers 3Huntington Memorial Hospital Becomes First in the San Gabriel Valley to Offer Patients a New Heart Failure Monitoring Solution 2Huntington Memorial Hospital Becomes First in the San Gabriel Valley to Offer Patients a New Heart Failure Monitoring Solution 3HYPR Corp. Joins the FIDO Alliance 2HYPR Corp. Joins the FIDO Alliance 3
... , June 11, 2013 Intelligent building industry ... costing (LCC) as a valid prerequisite in the process ... presently, use of LCC to determine long-term return on ... are a long-term commitment in most cases, making well-informed ...
... (HCV) infects more than 170 million people worldwide. Approximately ... fibrosis, cirrhosis, cancer and also hepatic iron overload. A ... Stritch School of Medicine reveals that HCV not only ... receptor 1 (TfR1) but that TfR1 also mediates HCV ...
... than a decade, scientists have suspected that hairpin-shaped chains of ... NC State University have found the first example and mapped ... research, published online in Proceedings of the National Academy ... one strand of micro-RNA reduced by more than 20 percent ...
Cached Biology News:A Future-Proof Approach to Intelligent Buildings 2A Future-Proof Approach to Intelligent Buildings 3A Future-Proof Approach to Intelligent Buildings 4New Loyola study on hepatitis C virus entry factor 2
... UNIchip AV-400 contains 400 unique ... nitrocellulose-coated glass slide. The proteins, a ... are arrayed in quadruplicate for high-quality ... specific chip layout guarantee high validity ...
... UNIchip AV-400 contains 400 unique human ... glass slide. The proteins, all extracellular ... classification, are arrayed in quadruplicate for ... a specific chip layout guarantee high ...
... Sub-Plates are E.Coli glycerol stocks contained in ... 50 cDNA clones with approximately 5,000 clones ... a master plate well, the corresponding subplate ... to identify the positive well(s). Cells from ...
... Lysate Systems(a,b,c,d) offer researchers an alternative ... single-tube, coupled transcription/translation system. The TNT ... and reduce the time required to ... rabbit reticulocyte lysate translations (1) commonly ...
Biology Products: